Aclaris Therapeutics ACRS Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aclaris Therapeutics's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aclaris Therapeutics's software and technology licenses, net?
- Aclaris Therapeutics (ACRS) reported software and technology licenses, net of $2.37M in Q1 2026.
- How has Aclaris Therapeutics's software and technology licenses, net changed year-over-year?
- Aclaris Therapeutics's software and technology licenses, net decreased by 24.8% year-over-year, from $3.15M to $2.37M.
- What is the long-term trend for Aclaris Therapeutics's software and technology licenses, net?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's software and technology licenses, net has grown at a -9.3% compound annual growth rate (CAGR), from $4.51M to $2.77M.